Chantal Pharand

1.4k total citations
40 papers, 1.0k citations indexed

About

Chantal Pharand is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Chantal Pharand has authored 40 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cardiology and Cardiovascular Medicine, 11 papers in Internal Medicine and 9 papers in Surgery. Recurrent topics in Chantal Pharand's work include Antiplatelet Therapy and Cardiovascular Diseases (21 papers), Venous Thromboembolism Diagnosis and Management (11 papers) and Atrial Fibrillation Management and Outcomes (10 papers). Chantal Pharand is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (21 papers), Venous Thromboembolism Diagnosis and Management (11 papers) and Atrial Fibrillation Management and Outcomes (10 papers). Chantal Pharand collaborates with scholars based in Canada, United States and United Kingdom. Chantal Pharand's co-authors include Jean G. Diodati, Thùy Anh Nguyễn, Marie Lordkipanidzé, Donald Palisaitis, Érick Schampaert, David Williamson, Simon de Denus, Pierre Théroux, Steven Snapinn and Margaret L. Ackman and has published in prestigious journals such as Circulation, Blood and Journal of the American College of Cardiology.

In The Last Decade

Chantal Pharand

38 papers receiving 968 citations

Peers

Chantal Pharand
Wei C. Lau United States
Anne Bellemain-Appaix France
Mette Hurlen Norway
Masafumi Ueno Japan
Paul A. Gurbel United States
Yongwhi Park South Korea
Seok‐Jae Hwang South Korea
Govinda Weerakkody United States
Paul H. Tanser Canada
Christoph Varenhorst Sweden
Wei C. Lau United States
Chantal Pharand
Citations per year, relative to Chantal Pharand Chantal Pharand (= 1×) peers Wei C. Lau

Countries citing papers authored by Chantal Pharand

Since Specialization
Citations

This map shows the geographic impact of Chantal Pharand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chantal Pharand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chantal Pharand more than expected).

Fields of papers citing papers by Chantal Pharand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chantal Pharand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chantal Pharand. The network helps show where Chantal Pharand may publish in the future.

Co-authorship network of co-authors of Chantal Pharand

This figure shows the co-authorship network connecting the top 25 collaborators of Chantal Pharand. A scholar is included among the top collaborators of Chantal Pharand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chantal Pharand. Chantal Pharand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lordkipanidzé, Marie, Jean G. Diodati, Érick Schampaert, Donald Palisaitis, & Chantal Pharand. (2014). Evidence of platelet sensitization to ADP following discontinuation of clopidogrel therapy in patients with stable coronary artery disease. Platelets. 26(6). 545–551. 6 indexed citations
2.
Laurier, Claudine, et al.. (2011). Case Study of Generic Competencies Assessment. Pharmacy Education. 11.
3.
Lordkipanidzé, Marie, Jean G. Diodati, Donald Palisaitis, et al.. (2011). Genetic determinants of response to aspirin: Appraisal of 4 candidate genes. Thrombosis Research. 128(1). 47–53. 27 indexed citations
4.
Nguyễn, Thùy Anh, Marie Lordkipanidzé, Jean G. Diodati, et al.. (2009). Week‐Long High‐Maintenance Dose Clopidogrel Regimen Achieves Better Platelet Aggregation Inhibition than a Standard Loading Dose before Percutaneous Coronary Intervention: Results of a Double‐Blind, Randomized Clinical Trial. Journal of Interventional Cardiology. 22(4). 368–377. 7 indexed citations
5.
Lordkipanidzé, Marie, Jean G. Diodati, & Chantal Pharand. (2009). Possibility of a rebound phenomenon following antiplatelet therapy withdrawal: A look at the clinical and pharmacological evidence. Pharmacology & Therapeutics. 123(2). 178–186. 73 indexed citations
6.
Lordkipanidzé, Marie, Jean G. Diodati, Érick Schampaert, Donald Palisaitis, & Chantal Pharand. (2009). Prevalence of Unresponsiveness to Aspirin and/or Clopidogrel in Patients With Stable Coronary Heart Disease. The American Journal of Cardiology. 104(9). 1189–1193. 14 indexed citations
7.
Lordkipanidzé, Marie, Chantal Pharand, Donald Palisaitis, Érick Schampaert, & Jean G. Diodati. (2009). Insights into the interpretation of light transmission aggregometry for evaluation of platelet aggregation inhibition by clopidogrel. Thrombosis Research. 124(5). 546–553. 13 indexed citations
8.
Lordkipanidzé, Marie, Chantal Pharand, Érick Schampaert, Donald Palisaitis, & Jean G. Diodati. (2009). Evaluation of the platelet count drop method for assessment of platelet function in comparison with “gold standard” light transmission aggregometry. Thrombosis Research. 124(4). 418–422. 14 indexed citations
9.
Pharand, Chantal, et al.. (2009). Response to aspirin in healthy individuals. Thrombosis and Haemostasis. 102(8). 404–411. 58 indexed citations
10.
11.
Nguyễn, Thùy Anh, Jean G. Diodati, & Chantal Pharand. (2005). Resistance to clopidogrel: A review of the evidence. Journal of the American College of Cardiology. 45(8). 1157–1164. 390 indexed citations
12.
Denus, Simon de, Chantal Pharand, & David Williamson. (2004). Brain Natriuretic Peptide in the Management of Heart Failure. CHEST Journal. 125(2). 652–668. 64 indexed citations
13.
Bélanger, Patrick, Donald Palisaitis, Jean G. Diodati, & Chantal Pharand. (2003). Effects of High Ticlopidine Doses on Platelet Function in Acute Coronary Syndrome Patients. Journal of Cardiovascular Pharmacology. 43(1). 128–132. 2 indexed citations
14.
Palisaitis, Donald, et al.. (2003). Platelet activity and antibody titers after exposure to streptokinase or streptococcal infection. Thrombosis Research. 111(4-5). 243–249. 2 indexed citations
15.
Pharand, Chantal, et al.. (2002). A National Survey of Antimicrobial Prophylaxis in Adult Cardiac Surgery Across Canada. Canadian Journal of Infectious Diseases and Medical Microbiology. 13(1). 21–27. 6 indexed citations
16.
Pharand, Chantal, Donald Palisaitis, & Denis Hamel. (2002). Potential Anaphylactic Shock with Abciximab Readministration. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 22(3). 380–383. 12 indexed citations
17.
Williamson, David & Chantal Pharand. (1998). Statins in the Prevention of Coronary Heart Disease. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 18(2). 242–254. 3 indexed citations
18.
Pharand, Chantal, Richard A. Goldman, Chengde Fan, Moses Chow, & Jeffrey Kluger. (1996). Effect of Chronic Oral Moricizine and Intravenous Epinephrine on Ventricular Fibrillation and Defibrillation Thresholds. Pacing and Clinical Electrophysiology. 19(1). 82–89. 13 indexed citations
19.
Pharand, Chantal, et al.. (1995). Lidocaine prophylaxis for fatal ventricular arrhythmias after acute myocardial infarction*. Clinical Pharmacology & Therapeutics. 57(4). 471–478. 12 indexed citations
20.
Ujhelyi, Michael R., et al.. (1993). The pharmacokinetic and pharmacodynamic interaction between propafenone and lidocaine. Clinical Pharmacology & Therapeutics. 53(1). 38–48. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wei C. Lau Breakdown of academic impact, for papers by Anne Bellemain-Appaix Breakdown of academic impact, for papers by Mette Hurlen Breakdown of academic impact, for papers by Masafumi Ueno Breakdown of academic impact, for papers by Paul A. Gurbel Breakdown of academic impact, for papers by Yongwhi Park Breakdown of academic impact, for papers by Seok‐Jae Hwang Breakdown of academic impact, for papers by Govinda Weerakkody Breakdown of academic impact, for papers by Paul H. Tanser Breakdown of academic impact, for papers by Christoph Varenhorst
Rankless by CCL
2026